Novo Nordisk strikes deal with Iran government to produce insulin pens in the country

Eric Palmer

will step up its operations in , saying today it will build a €70 million ($ 78.1 million) plant to its FlexPen prefilled devices to better supply the with its products.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS